The Amano Enzyme team will be co-chairing and presenting in two separate sessions in the AOCS Technical Program, covering the ...

The mRNA technology behind the Pfizer and Moderna vaccines are groundbreaking, but their potential goes way beyond COVID-19.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions—but there is always room ...

Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the upcoming publication of its patent for an innovative enzymatic method to ...

Scientists created ‘venom maps’ to predict Russell’s viper venom profiles, which could help clinicians tailor efficient ...

Researchers have developed a machine learning model that predicts Cas9 proteins that can be tailored with designer properties for therapeutic use.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions-but there is always room for improvement.

A team at UCSF and Gladstone Institutes developed new drug candidates that show great promise against the virus that causes ...

Researchers have developed engineered human microglia that detect disease-related brain changes and release therapeutic ...